BRA
CLVS

Bender Robert & Associates’s Clovis Oncology, Inc. CLVS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-50,000
Closed -$60K 56
2022
Q3
$60K Hold
50,000
0.02% 50
2022
Q2
$90K Buy
+50,000
New +$90K 0.03% 51
2021
Q2
Sell
-50,000
Closed -$351K 57
2021
Q1
$351K Buy
+50,000
New +$351K 0.11% 47